Survival and mortality from COVID-19 in Bogota, Colombia during march and july 2020
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | spa |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/10049 |
Resumo: | Objective: To determine the survival rate of COVID-19 in Bogotá-Colombia between March and July 2020. Materials and Methods: a retrospective cohort study was made in a population infected by COVID-19 in Bogotá from March 6 to July 8, 2020. Incomplete data was excluded and data reported to the INS were used. Infected populations were confirmed via PCR test; the study time starts intiates during onset of symptoms until death or the final time of the cohort. For survival, the actuarial method, the Long-Rank test, was applied. Results: Survival rate on days 1, 10, 20 and 30, is of 100%, 99%, 98% and 96% respectively, (p <0.01) survival rate at 30 days in female sex is 97% and 95% male patients (HR = 1.4 95% CI 1.2-1.6), the 30-day survival rate of hospitalized patients is of 76%, and 100% in non-hospitalized patients (HR = 31.2 95% % 24.4-40), the age group with the lowest survival rate of 63% was the ≥80 years group (HR = 48.4 95% CI 27.5-85.2). Conclusion: The risk factors related to mortality in Bogotá-Colombia are male sex, advanced age, and hospitalization. The last two risk factors mentioned are risk factors known across multiple COVID-19 survival studies in different ethnic groups and locations. Meanwhile, male sex is not an universal risk factor, not seen in certain studies with different populations and ethnic groups. |
id |
UNIFEI_9efd6232f38de6aef0f1165de90ed625 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/10049 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Survival and mortality from COVID-19 in Bogota, Colombia during march and july 2020Supervivencia y mortalidad por COVID-19 en Bogotá, Colombia durante marzo y julio de 2020Sobrevivência e mortalidade da COVID-19 em Bogotá, Colômbia durante março e julho de 2020SARS-CoV 2COVID-19SurvivalMortalityRisk factors. SARS-CoV 2COVID-19SobrevivênciaMortalidadeFatores de risco. SARS-CoV 2COVID-19SupervivenciaMortalidadFactores de riesgo. Objective: To determine the survival rate of COVID-19 in Bogotá-Colombia between March and July 2020. Materials and Methods: a retrospective cohort study was made in a population infected by COVID-19 in Bogotá from March 6 to July 8, 2020. Incomplete data was excluded and data reported to the INS were used. Infected populations were confirmed via PCR test; the study time starts intiates during onset of symptoms until death or the final time of the cohort. For survival, the actuarial method, the Long-Rank test, was applied. Results: Survival rate on days 1, 10, 20 and 30, is of 100%, 99%, 98% and 96% respectively, (p <0.01) survival rate at 30 days in female sex is 97% and 95% male patients (HR = 1.4 95% CI 1.2-1.6), the 30-day survival rate of hospitalized patients is of 76%, and 100% in non-hospitalized patients (HR = 31.2 95% % 24.4-40), the age group with the lowest survival rate of 63% was the ≥80 years group (HR = 48.4 95% CI 27.5-85.2). Conclusion: The risk factors related to mortality in Bogotá-Colombia are male sex, advanced age, and hospitalization. The last two risk factors mentioned are risk factors known across multiple COVID-19 survival studies in different ethnic groups and locations. Meanwhile, male sex is not an universal risk factor, not seen in certain studies with different populations and ethnic groups. Objetivo: Determinar la supervivencia de COVID-19 en Bogotá-Colombia entre marzo y julio de 2020. Materiales y Métodos: Se realizó un estudio de cohortes retrospectivo en una población infectada por COVID-19 en Bogotá durante el 6 de marzo hasta el 8 de julio de 2020. Se excluyeron datos incompletos y se utilizaron datos reportados al INS. La población infectada se confirmó mediante la prueba PCR; el tiempo de estudio de esta población es desde el inicio de los síntomas hasta la defunción o el tiempo final de la cohorte. Para la supervivencia, se aplicó el método actuarial con la prueba Long-Rank. Resultados: La supervivencia en los días 1, 10, 20 y 30, es de 100%, 99%, 98% y 96% respectivamente (p<0,01). La supervivencia a los 30 días en sexo femenino es de 97% y de 95% en el masculino (HR=1,4 IC95% 1,2-1,6). La supervivencia en pacientes hospitalizados al día 30 es del 76% y del 100% en los no hospitalizados (HR=31,2 IC95% 24,4-40). El grupo de edad con menor supervivencia de 63% fue el grupo de ≥ 80 años (HR=48,4 IC95% 27,5-85,2). Conclusión: Los factores de riesgo relacionados con mortalidad en Bogotá-Colombia son el sexo masculino, la edad avanzada, y la hospitalización. Los últimos dos factores mencionados son factores de riesgo consistentemente observados en múltiples estudios de supervivencia por COVID-19 realizados en diferentes ciudades y grupos étnicos. Mientras tanto, el sexo masculino no es un factor universal, y solo es observado en ciertos estudios con diferentes poblaciones y grupos étnicos.Objetivo: Determinar a sobrevivência de COVID-19 em Bogotá-Colômbia entre março e julho de 2020. Materiais e métodos: O tipo de estudo foi coorte retrospectiva em uma população de pessoas infetadas com COVID-19 em Bogota entre o 6 de Março ao 8 de Julho de 2020, só foram utilizados os dados relatados ao INS. As pessoas infetadas foram relatadas por teste de PCR; o tempo de monitoramento foi a data de início dos sintomas até a data da morte ou até o tempo final da coorte que é o 8 de Julho. Para a sobrevivência foi aplicado o método atuarial, a prova Long-Rank. Resultados: determinar a sobrevivência pelos dias 1, 10, 20 e 30 a sobrevivência foi de 100%, 99%, 98% e 96% respetivamente. Foram encontradas diferenças na sobrevivência da idade, sexo e hospitalização (p<0,01), a sobrevivência aos 30 dias no sexo feminino foi 97% e no sexo masculino do 95% (HR=1,4 IC95% 1,2-1,6), os pacientes hospitalizados tiveram uma sobrevivência aos 30 dias de 76% e o grupo não hospitalizado de 100% (HR=31,2 IC95% 24,4-40), o grupo da idade com menor sobrevivência foram os ≥ 80 anos com um 63% % (HR=48,4 IC95% 27,5-85,2). Conclusão: Os fatores de risco que poderiam ser atribuídos ao aumento da tasa da mortalidade em Bogota-Colômbia são o sexo masculino, a idade avançada e a hospitalização. Os dois últimos fatores de risco mencionados são fatores de risco bem estabelecidos entre vários estudos de sobrevivência do COVID-19 em diferentes grupos étnicos e cidades.Research, Society and Development2020-12-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1004910.33448/rsd-v9i11.10049Research, Society and Development; Vol. 9 No. 11; e81291110049Research, Society and Development; Vol. 9 Núm. 11; e81291110049Research, Society and Development; v. 9 n. 11; e812911100492525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIspahttps://rsdjournal.org/index.php/rsd/article/view/10049/9376Copyright (c) 2020 Carlos Santiago Esteban Rodriguez; Andres Ricardo Lopez Tovar; Gustavo Adolfo Uriza Jaramillo; Edwin Andrés Bustos Rodríguez; Edgar Antonio Ibáñez Pinilla; Jeadran Nevardo Malagón Rojashttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRodriguez, Carlos Santiago Esteban Tovar, Andres Ricardo Lopez Jaramillo, Gustavo Adolfo Uriza Rodríguez, Edwin Andrés Bustos Pinilla, Edgar Antonio Ibáñez Rojas, Jeadran Nevardo Malagón 2020-12-10T23:37:57Zoai:ojs.pkp.sfu.ca:article/10049Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:32:11.590527Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Survival and mortality from COVID-19 in Bogota, Colombia during march and july 2020 Supervivencia y mortalidad por COVID-19 en Bogotá, Colombia durante marzo y julio de 2020 Sobrevivência e mortalidade da COVID-19 em Bogotá, Colômbia durante março e julho de 2020 |
title |
Survival and mortality from COVID-19 in Bogota, Colombia during march and july 2020 |
spellingShingle |
Survival and mortality from COVID-19 in Bogota, Colombia during march and july 2020 Rodriguez, Carlos Santiago Esteban SARS-CoV 2 COVID-19 Survival Mortality Risk factors. SARS-CoV 2 COVID-19 Sobrevivência Mortalidade Fatores de risco. SARS-CoV 2 COVID-19 Supervivencia Mortalidad Factores de riesgo. |
title_short |
Survival and mortality from COVID-19 in Bogota, Colombia during march and july 2020 |
title_full |
Survival and mortality from COVID-19 in Bogota, Colombia during march and july 2020 |
title_fullStr |
Survival and mortality from COVID-19 in Bogota, Colombia during march and july 2020 |
title_full_unstemmed |
Survival and mortality from COVID-19 in Bogota, Colombia during march and july 2020 |
title_sort |
Survival and mortality from COVID-19 in Bogota, Colombia during march and july 2020 |
author |
Rodriguez, Carlos Santiago Esteban |
author_facet |
Rodriguez, Carlos Santiago Esteban Tovar, Andres Ricardo Lopez Jaramillo, Gustavo Adolfo Uriza Rodríguez, Edwin Andrés Bustos Pinilla, Edgar Antonio Ibáñez Rojas, Jeadran Nevardo Malagón |
author_role |
author |
author2 |
Tovar, Andres Ricardo Lopez Jaramillo, Gustavo Adolfo Uriza Rodríguez, Edwin Andrés Bustos Pinilla, Edgar Antonio Ibáñez Rojas, Jeadran Nevardo Malagón |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Rodriguez, Carlos Santiago Esteban Tovar, Andres Ricardo Lopez Jaramillo, Gustavo Adolfo Uriza Rodríguez, Edwin Andrés Bustos Pinilla, Edgar Antonio Ibáñez Rojas, Jeadran Nevardo Malagón |
dc.subject.por.fl_str_mv |
SARS-CoV 2 COVID-19 Survival Mortality Risk factors. SARS-CoV 2 COVID-19 Sobrevivência Mortalidade Fatores de risco. SARS-CoV 2 COVID-19 Supervivencia Mortalidad Factores de riesgo. |
topic |
SARS-CoV 2 COVID-19 Survival Mortality Risk factors. SARS-CoV 2 COVID-19 Sobrevivência Mortalidade Fatores de risco. SARS-CoV 2 COVID-19 Supervivencia Mortalidad Factores de riesgo. |
description |
Objective: To determine the survival rate of COVID-19 in Bogotá-Colombia between March and July 2020. Materials and Methods: a retrospective cohort study was made in a population infected by COVID-19 in Bogotá from March 6 to July 8, 2020. Incomplete data was excluded and data reported to the INS were used. Infected populations were confirmed via PCR test; the study time starts intiates during onset of symptoms until death or the final time of the cohort. For survival, the actuarial method, the Long-Rank test, was applied. Results: Survival rate on days 1, 10, 20 and 30, is of 100%, 99%, 98% and 96% respectively, (p <0.01) survival rate at 30 days in female sex is 97% and 95% male patients (HR = 1.4 95% CI 1.2-1.6), the 30-day survival rate of hospitalized patients is of 76%, and 100% in non-hospitalized patients (HR = 31.2 95% % 24.4-40), the age group with the lowest survival rate of 63% was the ≥80 years group (HR = 48.4 95% CI 27.5-85.2). Conclusion: The risk factors related to mortality in Bogotá-Colombia are male sex, advanced age, and hospitalization. The last two risk factors mentioned are risk factors known across multiple COVID-19 survival studies in different ethnic groups and locations. Meanwhile, male sex is not an universal risk factor, not seen in certain studies with different populations and ethnic groups. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-04 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/10049 10.33448/rsd-v9i11.10049 |
url |
https://rsdjournal.org/index.php/rsd/article/view/10049 |
identifier_str_mv |
10.33448/rsd-v9i11.10049 |
dc.language.iso.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/10049/9376 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 9 No. 11; e81291110049 Research, Society and Development; Vol. 9 Núm. 11; e81291110049 Research, Society and Development; v. 9 n. 11; e81291110049 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052663766974464 |